Malignant peripheral nerve sheath tumours in NF1: improved survival in women and in recent years.
AffiliationGenetic Medicine, The University of Manchester, Manchester Academic Health Science Centre, Central Manchester Foundation Trust, St. Mary's Hospital, UK.
MetadataShow full item record
AbstractMalignant peripheral nerve sheath tumours (MPNST) are the main soft tissue malignancy associated with neurofibromatosis 1. These uncommon tumours are known to occur at high frequency and lead to poor survival. Our aim was to determine risk of MPNST in NF1 patients, and survival rates.
CitationMalignant peripheral nerve sheath tumours in NF1: improved survival in women and in recent years. 2011, 47 (18):2723-8 Eur J Cancer
JournalEuropean Journal of Cancer
- Malignant peripheral nerve sheath tumors (MPNST) in NF1-affected children.
- Authors: Friedrich RE, Hartmann M, Mautner VF
- Issue date: 2007 Jul-Aug
- Further evidence of the increased risk for malignant peripheral nerve sheath tumour from a Scottish cohort of patients with neurofibromatosis type 1.
- Authors: McCaughan JA, Holloway SM, Davidson R, Lam WW
- Issue date: 2007 Jul
- Malignant peripheral nerve sheath tumours in neurofibromatosis 1.
- Authors: Evans DG, Baser ME, McGaughran J, Sharif S, Howard E, Moran A
- Issue date: 2002 May
- Malignant peripheral nerve sheath tumors in neurofibromatosis 1.
- Authors: King AA, Debaun MR, Riccardi VM, Gutmann DH
- Issue date: 2000 Aug 28
- Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1.
- Authors: Kolberg M, Høland M, Agesen TH, Brekke HR, Liestøl K, Hall KS, Mertens F, Picci P, Smeland S, Lothe RA
- Issue date: 2013 Feb